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Moderate Nucleoporin 133 
deficiency leads to glomerular 
damage in zebrafish
Chiara Cianciolo Cosentino1,4,5, Alessandro Berto2,3, Stéphane pelletier2, Michelle Hari1, 
Johannes Loffing4, Stephan C. F. Neuhauss1 & Valérie Doye2
Although structural nuclear pore proteins (nucleoporins) are seemingly required in every cell type to 
assemble a functional nuclear transport machinery, mutations or deregulation of a subset of them 
have been associated with specific human hereditary diseases. In particular, previous genetic studies 
of patients with nephrotic syndrome identified mutations in Nup107 that impaired the expression or 
the localization of its direct partner at nuclear pores, Nup133. In the present study, we characterized 
the zebrafish nup133 orthologous gene and its expression pattern during larval development. Using 
a morpholino-mediated gene knockdown, we show that partial depletion of Nup133 in zebrafish 
larvae leads to the formation of kidney cysts, a phenotype that can be rescued by co-injection of 
wild type mRNA. Analysis of different markers for tubular and glomerular development shows that 
the overall kidney development is not affected by nup133 knockdown. Likewise, no gross defect in 
nuclear pore complex assembly was observed in these nup133 morphants. On the other hand, nup133 
downregulation results in proteinuria and moderate foot process effacement, mimicking some of the 
abnormalities typically featured by patients with nephrotic syndrome. These data indicate that nup133 
is a new gene required for proper glomerular structure and function in zebrafish.
Efficient and regulated bidirectional transport between the cytoplasm and the nucleus is an essential process in all 
eukaryotic cells. This function is achieved by nuclear pore complexes (NPCs), huge assemblies anchored within 
the nuclear envelope and composed of about 30 different proteins, termed nucleoporins (Nups) (reviewed in1). 
Despite the universal role of NPCs in all nucleated cells, some Nups are linked to human hereditary diseases 
affecting specific cell types or organs (reviewed in2–4).
In particular, genetic studies have implicated a restricted number of structural nucleoporins in specific kidney 
diseases termed nephrotic syndromes (NS). NS arise from defects or damages that impair the selectivity of the 
glomerular filtration barrier and lead to massive proteinuria and hypoalbuminemia, which in turn cause edema 
and dyslipidemia. The glomerular filtration barrier (GFB) surrounds the glomerular capillaries and comprises 
three layers: (i) a fenestrated endothelium, (ii) a basement membrane, and (iii) the podocytes. The latter are 
highly specialized epithelial cells characterized by long and thin cytoplasmic projections, termed foot processes 
(FPs), that interdigitate and are connected by specialized cell-cell junctions, the slit diaphragms (reviewed in5). 
While most patients with childhood-onset NS respond well to steroid treatments, 10–20% of the affected chil-
dren do not achieve remission upon corticosteroid therapy. Steroid-resistant NS (SRNS) is associated with a high 
risk of progression to end-stage renal disease (ESRD)6. It frequently manifests histologically as focal segmental 
glomerulosclerosis (FSGS), characterized by scattered scarring of some glomeruli and is often associated with 
retractions (“effacement”) of podocytes foot processes (reviewed in7).
Although nonhereditary forms of SRNS seem to be prevalent, studies over the last years have identified over 
50 dominant or recessive single-gene mutations in a significant percentage (30%) of patients with early-onset 
SRNS and FSGS (reviewed or discussed in6,8–11). While some of these genes have podocyte-specific or -restricted 
functions, these studies also unveiled the implication of multiple cellular processes in the establishment or main-
tenance of the glomerular filtration barrier7,12,13. In particular, these genetic studies have identified mutations 
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in Nup93 and Nup205, two constituents of the inner ring of the NPC14 and in Nup107, a constituent of the 
Y-complex (Nup107/160-complex) that builds up the cytoplasmic and nuclear rings of the NPC15–17. Mutations 
within Nup107 were also identified in patients with a rare co-occurrence of microcephaly with nephrotic syn-
drome, similar to Galloway-Mowat syndrome (GAMOS)18. While patients with GAMOS-like presentation had a 
strong reduction in Nup107 protein level accompanied by decreased levels of Nup133, its direct partners within 
the Y-complex18, another SRNS-linked mutation affecting Nup107 was shown to impair its interaction with 
Nup13316. These data thus pointed towards a possible implication of Nup133 in NS.
In mice, a previous characterization of a Nup133 null mutant (mermaid, or merm) revealed that mouse 
embryos lacking a functional Nup133 allele developed through midgestation but die at e9.5–e10.519. While this 
indicates that Nup133 is not an obligate NPC component, merm mutants displayed abnormalities in a number 
of tissues, indicating that cell differentiation towards several epiblast-derived lineages likely requires Nup13319. 
However, the possible contribution of Nup133 to kidney development or function has never been assessed. 
To address this question, we used morpholino-mediated nup133 inactivation in zebrafish (Danio rerio, Dr), a 
well-established vertebrate model to study kidney development and renal diseases20–23. We report here that lim-
ited knockdown of zebrafish nup133, while not impairing early stages of kidney development, leads to glomerular 
abnormality that mimic nephrotic syndrome.
Results
Zebrafish nup133 ortholog is broadly expressed at early stages and becomes restricted to spe-
cific tissues at later stages. Query of the latest version of the genome databases identified a unique nup133 
orthologue gene in zebrafish, Dr nup133 (ZFIN:ZDB-GENE-040426-2941; Ensembl:ENSDARG00000010078) 
containing 26 exons located on the forward strand of chromosome 1. The open reading frame is predicted to 
encode a protein of 1136 amino acids (aa) that shares 62.3% overall amino acid identity with human Nup133 
(Supplementary Fig. S1).
To determine the spatio-temporal localization of nup133 transcripts in zebrafish embryonic tissues, we per-
formed whole-mount in situ hybridization (ISH) at different developmental stages (Fig. 1a–f). The nup133 sense 
RNA probe was used as negative control (Supplementary Fig. S2). Ubiquitous expression of nup133 was observed 
at sphere stage (4 hours post fertilization, hpf, Fig. 1a and Supplementary Fig. S2). By 24 hpf, nup133 mRNA 
was detected in the central nervous system, with higher levels of expression in the retina, the tectum and the 
cerebellum (Fig. 1b). At 3 days post fertilization (dpf), in addition to a diffuse staining notably in the brain, 
we found evidence of nup133 mRNA enrichment in the liver, in the intestine and in neuromasts of the lateral 
line organ (Fig. 1c,d). At 5 dpf, the overall expression of nup133 is weaker, but the mRNA is still detectable in 
the brain, and enriched in the liver, the intestine and the swim bladder (Fig. 1e,f). Cross sections at 4 and 5 dpf 
confirmed the enrichment of nup133 mRNA in the liver and revealed the presence of nup133 mRNA also in the 
pronephric proximal tubules and the glomerulus, albeit in low amounts (Fig. 1g, and Supplemental Fig. S2). 
Figure 1. Expression of nup133 in the developing zebrafish detected by in situ hybridization (ISH). Whole 
mount ISH with nup133 antisense probe of embryos at: (a) sphere stage (4 hpf; embryo shown with animal pole 
to the top); (b) 24 hfp (lateral view); (c–f) 3 and 5 dpf (left panels: dorsal view; right panels: lateral view). Arrows 
point to tissues with enriched expression of nup133. Abbreviations: E: eyes; T: tectum; C: cerebellum; L: liver; I: 
intestine; N: neuromasts; SB: swim bladder. Scale bars, 200 µm. (g) Transverse section of a 5 dpf embryo at the 
level of the pectoral fins (as shown in the dotted line in e) confirms nup133 expression in the liver, and show 
in addition a diffuse staining in the proximal tubules (PT) and a faint signal in the glomerulus (G). Scale bar, 
50 µm.
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Consistent with these ISH data and with a previous genome wide RNA-seq dataset24 quantitative RT-PCR per-
formed at 1, 2 and 5 dpf revealed a progressive decrease of nup133 mRNA level during development as compared 
to beta2 actin mRNA (actb2, previously reported to be extremely stable at these stages of zebrafish development 
(Supplementary Fig. S2f)24,25.
Partial loss of nup133 causes glomerular cysts in zebrafish. In order to characterize the in vivo func-
tion of nup133 in zebrafish larvae, we generated knockdown larvae using splice-blocking antisense morpholino 
oligos (MO) targeting the exon-intron boundary (splice donor E3I3) of exon 3 and the intron-exon boundary of 
exon 4 (splice acceptor I3E4) of the nup133 gene (Fig. 2a). Reverse transcription-PCR (RT-PCR) demonstrated 
that the morpholinos interfere with the splicing of exon 3, as revealed by the sequencing of the additional RT-PCR 
product detected in MO-treated compared to control embryos (Fig. 2a,b and Supplemental Fig. S3). Retention 
of intron 3 in nup133 transcripts is predicted to produce a truncated protein of 124 aa. Quantitative analyses 
revealed that the levels of properly spliced nup133 mRNA (red and orange bars in Fig. 2c) drop to about 30% and 
40% in 24 and 48 hpf embryos respectively upon nup133 MO injection as compared to control embryos (unin-
jected or injected with control MO). These MO-injected embryos only contained 20–30% of intron 3-containing 
nup133 mRNAs (difference between the red/oranges and blue bars in Fig. 2c), indicating that most of the intron 
3-containing mRNAs, which encode premature stop codons, are degraded via non-sense mediated mRNA decay. 
Western blot analysis confirmed these data by revealing a clear albeit moderate decrease of Nup133 protein level 
in 24 hpf embryos (Supplemental Fig. S3).
Following nup133 MOs injections, zebrafish larvae frequently developed pericardial edema and exhibited an 
expansion of the glomerulus detectable at 3 dpf by the formation of pronephric cysts (Fig. 3a and Supplemental 
Fig. S3). Using the Tg(wt1b:eGFP) transgenic line26, in which podocytes and proximal pronephric tubules express 
EGFP under the wt1b promoter, the glomerular expansion could be directly observed under a fluorescence 
microscope (Fig. 3b,  asterisks). Analysis of semi-thin transverse sections of the glomerulus and proximal tubules 
at 5 dpf confirmed that the Bowman’s space of the glomerulus was dilated in nup133 morphants compared with 
the control larvae (Supplemental Fig. S3). To establish the specificity of MOs effects, we determined whether 
nup133 MO phenotypes could be rescued by co-injection of a synthetic zebrafish nup133 (Dr nup133) mRNA. 
The Dr nup133 mRNA was fused to a triple-hemagglutinin (HA) epitope and mCherry that enabled us to con-
firm the expression of the resulting 3xHA-mCherry-Dr Nup133 protein by western blot (Supplementary Fig. S4). 
Co-injection of the splice MOs with the 3xHA-mCherry-Dr nup133 mRNAs reduced significantly the percentage 
of larvae with glomerular cysts (Fig. 3c and Supplementary Fig. S4). This demonstrates that the glomerular phe-
notype observed in nup133 morphants is due to a specific effect of nup133 knockdown.
In the course of this study, we also noticed that the exocrine pancreas, an organ normally positioned on the 
right side of the zebrafish embryo and visualized by the wt1b:GFP transgene in 3 dpf embryos, was misplaced in 
Figure 2. Splice Morpholinos (MO) targeting nup133 lead to a partial degradation of nup133 mRNAs. (a) 
Exon structure of Danio rerio (Dr) nup133 around the binding sites of the E3I3 and I3E4 splice morpholinos. 
Blue arrowheads above the scheme indicate the position of the RT-PCR primers used in (b) and blue/red/
orange arrows below indicate the position of primers and RT-qPCR products used in (c). The size of intron 3 
is indicated. (b) RT-PCR from total RNAs of 48 hpf uninjected embryos (control) and of embryos coinjected 
with the two splicing morpholinos (nup133 MO) reveal an additional band caused by retention of intron 3. 
(c) nup133 mRNA levels relative to actb2 expression was determined by RT-qPCR on 24 and 48 hpf embryos, 
uninjected, injected with control MO or nup133 MO, or sequentially injected with 3xHA-mCherry-Dr nup133 
mRNA (wt mRNA) and nup133 MO. The E3-E4/5 (red) and E3/4-E4/5′ (orange) primer pairs only amplify 
nup133 mRNA with properly spliced intron 3 (i.e. wt nup133 mRNA not targeted by the morpholinos) while the 
E1/2-E3 and E7/8-E9 primer pairs (blue bars) recognize both the spliced and unspliced mRNAs.
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about 15–20% of the nup133 morphants (Supplemental Fig. S5). Analysis of heart looping in 2 dpf embryos con-
firmed this Left-Right patterning defect27 (Supplemental Fig. S5). Importantly however, and unlike the frequency 
of kidney cysts, these Left-Right patterning defects that are classically linked to ciliopathy were not rescued by 
injection of the 3xHA-mCherry-Dr nup133 mRNA (Arrowhead in Fig. 3b and Supplemental Fig. S5). This indi-
cates that the appearance of kidney cysts upon partial nup133 knockdown is not correlated with a Left-Right pat-
terning defect and may therefore not result from a primary defect in cilia assembly or function (see discussion).
Finally, because mutations of Nup107 that affect the stability of Nup133, also leads to microcephaly in human 
patients18, we measured the size of the heads of control, nup133 MO and nup133 MO + wt nup133 mRNA 
embryos at 3 dpf. While a very mild decrease of head width and length was observed in nup133 morphants as 
compared to control embryos, this defect was not rescued by injection of nup133 mRNA (Supplemental Fig. S5). 
This slight delay in development may thus reflect unspecific effects of the morpholinos28 rather than a specific 
effect of nup133 downregulation.
Figure 3. Partial knockdown of nup133 causes glomerular expansion in zebrafish. (a) Gross morphology of 
3 dpf control and nup133 MO embryos (left panels: lateral view; middle panel: dorso-lateral view from two 
distinct embryos). Scale bar, 500 µm. Two-fold magnification of the indicated area is shown in the rightmost 
panels. Arrows indicate the pronephric cysts detected in the nup133 MO embryos. (b) Dorsal view of 3dpf 
Tg(wt1b:EGFP) embryos uninjected (control, top panels), injected with nup133 MO (middle panels), or 
sequentially injected with 3xHA-mCherry-Dr nup133 mRNA (wt mRNA) and nup133 MO (bottom panels). 
Overlays of transmission (gray) and GFP-signal (green) images reveal the glomerulus, proximal tubules, and 
exocrine pancreas. Scale bar, 500 µm. Two-fold magnification of the indicated area and of the same area from a 
distinct larvae are shown in the right and rightmost panels, respectively. The glomerular structure is indicated 
in brackets. Asterisks point to cystic dilations of the pronephros in nup133 MO (middle panels). Note that the 
nup133 MO + wt mRNA embryo displays a left-sided exocrine pancreas (arrowhead) (see also Supplemental 
Fig. S5). (c) Relative proportion of embryos showing or not kidney cysts at 3 dpf. For each condition, the total 
number of embryos analyzed is indicated (n=, quantified in 2 distinct experiments for control MO injections 
and 5 experiments for nup133 MO injections. See also Supplementary Fig. S3). Unlike the embryos injected 
with control MO, those injected with nup133 MO frequently feature kidney cysts. On the other hand nup133 
MO + wt mRNA showed significantly fewer cysts than nup133 MO alone. ***P < 0.0001 using a Fisher exact 
probability test.
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nup133 morphants do not feature major NPC assembly defects and properly express molecu-
lar markers of kidney development. Because Nup133 is a structural nucleoporin, we next analyzed the 
consequence of its partial depletion on NPC assembly, using as readout the mAb414 antibody that recognizes 
a subset of FG-containing nucleoporins29. We therefore stained cryosections of 3 dpf Tg(wt1b:EGFP) embryos 
either treated with control MO or treated with nup133 MO and featuring detectable kidney cysts. While this 
analysis uncovered a large variability of staining intensity in-between tissues in the control embryos, it did not 
reveal major alterations of the NPC density in the nup133 MO compared to control MO-treated embryos (Fig. 4). 
Although specific alteration of a given nucleoporin cannot be excluded, these data suggest that unlike previously 
reported for Nup107 depletion in zebrafish30 the partial depletion of Nup133 does not affect the overall assembly 
of NPCs.
Figure 4. Nup133 depletion does not result in major nuclear pore complex assembly defects. (a) Representative 
transverse sections of the glomerulus of 3 dpf Tg(wt1b:EGFP) embryos treated with either control or nup133 
morpholinos (MO) and stained with mAb414 (not shown in these panels) and DAPI. In these sections, GFP-
positive cells mark the glomerulus and the neck region of the proximal tubules. Scale bars, 100 μm. (b) Fivefold 
magnification of the areas indicated in (a) encompassing the glomerulus (G, indicated by the dashed lines) and 
the liver (L). mAb414 antibody, that recognizes a subset of FG-nucleoporins, shows specific staining around the 
nucleus of all cells (visualized with DAPI), with however cell-type-dependent variations in intensity. Note for 
instance the more prominent staining of liver as compared to glomerular cells. In contrast, no major difference 
can be seen between control and nup133 MO-treated embryos. Insets show a fourfold magnification of 
representative liver nuclei, revealing the punctate staining typical of NPC staining (mAb414). Scale bars, 20 μm.
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We next wanted to determine whether the glomerular expansion in nup133 morphants is caused by a develop-
mental defect of the glomerulus and/or of the pronephros. For this purpose, we used whole-mount ISH to screen 
established markers of pronephros and glomerulus development. We first assayed expression of the intermediate 
mesoderm marker pax2a (paired box gene 2a). At 24 hpf, pax2a is expressed during early somitogenesis in the 
developing pronephric tubules and is important in establishing the boundary between podocytes and the neck 
segment of the nephron31,32. In nup133 morphants, expression of pax2a at 24 hpf was similar to that of wild type 
embryos, suggesting that the tubular development is not compromised in the morphants (Fig. 5a). We further 
examined the pronephric tubules and ducts in nup133 knockdown embryos by checking the expression of the 
kidney specific marker cadherin 17 (cdh17) at 24 hpf and 72 hpf. Again, no obvious difference in expression of 
cdh17 was observed between control and nup133 morphant larvae at 24 or 72 hpf (Fig. 5b). Based on these mark-
ers, we conclude that tubular development is not impaired upon nup133 knockdown.
We next used an mRNA probe for Wilms tumor suppressor 1a (wt1a) that is predominantly expressed in 
podocytes throughout pronephric development33. At 24 hpf, wt1a is still expressed in two distinct domains, the 
glomerular primordials, that fuse to form a single glomerulus by 40 hpf34,35. In nup133 morphants, expression of 
wt1a was comparable at 30 and 48 hpf to that of wild type embryos (Fig. 5c). wt1a expression sometimes revealed 
some glomerular enlargement already at 48hpf, a phenotype that became more evident at 58 hpf, after the onset 
of the glomerular filtration (Fig. 5c, bottom panels). Nevertheless, wt1a transcripts were still expressed in nup133 
morphants podocytes. These results suggest that knockdown of nup133 does not affect the gross development of 
zebrafish glomerulus.
nup133 deficiency affects the normal function of the glomerular filtration barrier. Because the 
glomerular enlargement upon nup133 knockdown becomes striking at the onset of glomerular filtration, we next 
analyzed the functionality of the pronephros in the morphant larvae. The glomerular filtration barrier (GFB) of 
the kidney allows the free filtration of water and small solutes, while restricting the flow of large plasma proteins 
such as albumin36. However, if the GFB is damaged, albumin and other large proteins pass the barrier to a great 
extent. Part of the albumin is endocytosed by the epithelial cells of the proximal tubules, while the rest gets then 
excreted via the final urine leading to proteinuria. In zebrafish larvae, it is possible to inject fluorescent com-
pounds of specific size into the general circulation and then to monitor the appearance of fluorescent endosomes 
in the apical cytoplasm of pronephric tubule cells37,38. To assay for kidney function, we therefore injected fluores-
cently labeled albumin from Bovine Serum (BSA, Alexa Fluor™ 647 conjugate) into the common cardinal vein 
of wild type and nup133 morphant larvae at 4 dpf and then examined the appearance of fluorescent endosomes 
in the cytoplasm of pronephric tubule cells. Larvae were fixed 20 minutes after BSA injections and sections of the 
pronephric proximal tubules were imaged. In the control larvae (n = 6, arising from two distinct experiments), 
we did not observe fluorescent signal from the injected BSA in the apical endosomes of the proximal tubules, 
indicating that BSA was not able to pass through the intact filtration barrier (Fig. 6, left panels). In most (5/6 
imaged larvae) nup133 morphants, however, fluorescently labeled endosomes were detectable in the proximal 
tubules (Fig. 6, right panels). This suggests that the filtration barrier of the glomerulus is impaired upon nup133 
knockdown, allowing the passage of macromolecules with a size exceeding the size selectivity of an intact GFB, 
a condition defined in patients as proteinuria. A statistically relevant analysis of phenotypic rescue would have 
required BSA injection and imaging of more than 100 embryos and was thus not performed. However, the BSA 
filtration defects observed in the nup133 morphants are consistent with the presence of kidney cysts (a phenotype 
that we could successfully rescue with injections of mRNA). This suggests that the altered functionality of the 
GFB is most likely a specific consequence of nup133 knockdown.
nup133 knockdown leads to ultrastructural abnormalities of the glomerular filtration barrier. 
In order to determine whether the glomerular filtration impairment observed in nup133 morphants was a conse-
quence of a defect in the glomerular filtration barrier (GFB), we conducted electron microscopy studies to com-
pare the ultrastructure of the glomerulus in nup133 morphants and wild type larvae at 5 dpf, a time point when 
the larval glomerulus development is considered nearly complete34,39 (Fig. 7 and Supplementary Fig. S6). In wild 
type larvae, the glomerulus showed the typical organization with podocytes harboring well-developed interdigi-
tated foot processes on the outer side, and fenestrated endothelial cells on the inner side of the glomerular base-
ment membrane (GBM) (Fig. 7a–c). In nup133 knockdown larvae with kidney cysts, however, irregularly-shaped 
processes covering the GMB were frequently observed, although typical foot processes were still present in some 
regions (Fig. 7d–f). In addition to this moderate foot process effacement, more extreme alterations were observed 
around the expanded bowman space (Fig. 7h, and Supplementary Fig. S6). In the latter case, podocyte cell bodies 
in direct contact with the GBM were frequently observed (Supplementary Fig. S6). Quantification of foot pro-
cesses density along the basement membrane confirmed the disorganization of podocyte foot process architecture 
in the nup133 morphants (Fig. 7g). Observation of proximal tubules (PTs) revealed variable phenotypes in the 
morphants: a normal organization, with well-organized microvilli and ciliated cells was observed in morphants 
with a mild phenotype (Supplementary Fig. S7); in contrast larvae presenting a more severe phenotype featured 
also an expanded lumen and a less organized brush border (Supplementary Fig. S7). Multiple cross sections of 
cilia were nevertheless observed inside these expanded PT lumens (Supplementary Fig. S7). These ultrastruc-
tural data, combined with the observation of leakage and recapture of fluorescently labeled albumin, suggest 
that zebrafish nup133 is mainly required for the structural integrity of the GFB and that the observed defects in 
proximal tubules are secondary to an altered GFB.
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Figure 5. Normal development of the pronephric tubules and glomerulus in nup133 morphants. (a) Lateral 
view of pax2a mRNA expression in pronephric tubules at 24 hpf in uninjected (control) and nup133 MO-
injected embryos reveal that the developmental expression of pax2a is not altered in nup133 morphants. Two-
fold magnification of the pronephric tubules is also shown. (b) Pronephros marker cdh17 mRNA expression 
in nup133 MO is comparable to that of uninjected controls at 24 and 72 hpf (dorsal view). (c) Glomerular 
development in control and nup133 MO embryos visualized using the podocyte differentiation marker wt1a 
(dorsal view). At 30 hpf (upper panels), wt1a marks future podocytes with two distinct domains in both 
control and nup133 MO. At 48 hpf (middle panels), the glomerular primordia merge to the midline to form a 
single glomerulus. At these stages, mRNA expression does not differ between control and nup133 MO (middle 
panels). At 58 hpf (lower panels), after the onset of glomerular filtration, the increased area labeled by the wt1a 
probe (arrow) reflects the glomerular expansion observed in 7 out of 13 nup133 morphants analyzed. Scale bars, 
500 µm.
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Discussion
In this study we used zebrafish as model organism to evaluate the contribution of Nup133 to vertebrate kidney 
function. Using splice-blocking MO-based depletion of Nup133 followed by rescue experiments with nup133 
mRNA, we have identified nup133 as a new regulator of glomerular structure and functional integrity.
Our study of glomerulus and proximal tubules expression markers shows that the decreased level of Nup133 
does not affect the initial stages of nephron development. In addition, TEM analysis of the glomerulus of 
Nup133-depleted zebrafish reveals that all the cell types constituting the GFB, including the podocytes, are in 
place. However, the podocytes of Nup133-depleted zebrafish present some degrees of effacement that correlate 
with a defective GFB. This result therefore suggests that Nup133 plays a fundamental role in the maintenance 
rather than in the establishment of the GFB.
While we describe here a kidney-specific alteration caused by a moderate depletion of Nup133, Fujita et al.40 
very recently reported a translation-blocking morpholino leading to a more efficient depletion of Nup133 protein 
level in zebrafish and causing both glomerular defects and microcephaly. On the same line, more severe develop-
mental phenotypes were previously observed upon Nup133 inactivation in mouse19. Similarly, while MO-induced 
depletion of zebrafish Nup107 mainly causes glomerular defects16, transposon insertion in nup107tsu068Gt trans-
genic embryos affects multiple tissues including the pharyngeal skeleton, the intestine, the swim bladder and the 
eyes30,41, and a CRISPR/Cas9-generated homozygous truncating “null” mutation of nup107 showed early lethality 
at 5 dpf associated with developmental malformations42. Together, these data indicate that the extent of depletion 
of structural nucleoporins can lead to distinct graded phenotypes in zebrafish, and that the kidney appears to be 
the organ with the highest sensitivity to moderate Nup133 or Nup107 deficiencies.
As we submitted our manuscript, the only Y-complex nucleoporin gene found to be mutated in SRNS was 
Nup10715–18. In addition, a study had revealed that normal expression level of another Y-complex component, 
Nup160, is critical for the proliferation and viability of podocytes in vitro43. Because our data indicated that 
Nup133, the direct partner of Nup107 within the Y-complex, is also required for proper glomerular function 
in zebrafish, we proposed that in addition to Nup107 at least these two other Y-Nups, or possibly all the nine 
Y-complex subunits (Nup107, Nup133, Nup160, Nup96, Nup85/75, Nup43, Nup37, Seh1, and Sec13) were candi-
date genes that would be worth testing in SRNS patients. While our manuscript was under revision, two publi-
cations came out that confirmed our hypothesis: specific hypomorphic mutations in 4 Y-complex components, 
namely Nup107, Nup133, Nup160 and Nup85 were reported to cause SRNS42 whereas a homozygous splicing 
mutation in NUP133 was identified in a GAMOS family with SRNS combined to brain atrophy40. Noteworthy, the 
mutation found in this GAMOS family caused reduced Nup133 protein level40, as also previously described for 
the consanguineous families with homozygous mutation in NUP107 and a GAMOS-like presentation18. Although 
Figure 6. Glomerular filtration is impaired in nup133 morphants. Representative images of cross sections of 
4 dpf control (left panels) and nup133 morphants larvae (right panels) fixed 20 minutes after injection of Alexa 
Fluor™ 647 conjugated-BSA into the common cardinal vein. Lower panels represent a higher magnification 
view of the proximal tubule region (dotted lines). Note the uptake of fluorescent BSA in the apical endosomes of 
the proximal tubules of the Nup133-depleted larva (arrows). Scale bars 50 µm.
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Nup133 protein levels were not investigated in patients solely featuring SRNS, the data obtained in zebrafish (our 
study and40) suggest that more severe alteration leading to decreased expression or stability of Nup133 would 
cause neuronal in addition to renal defects.
Figure 7. nup133 knockdown induces moderate foot processes effacement. (a,d) Transmission electron 
micrographs showing the glomerular capillary wall of 5 dpf uninjected control (a) and nup133 MO injected 
larvae (d). (b,e) Two-fold magnification of the areas indicated in (a,d), and (c,f,h) representative images from 
distinct larvae. Images were pseudocolored to better highlight the glomerular filtration barrier components 
(podocyte foot processes in green, fenestrated endothelium in blue). Arrows point to irregular-shaped foot 
processes that are more frequently found in nup133 MO larvae. (g) Quantification of foot processes (FP) density 
along the basement membrane, presented as average number of FP/µm, was performed as described under 
materials and methods. The distinct labels reflect values measured on the 3 wt or morphant embryos. Statistical 
analyses were performed using Wilcoxon-Mann-Whitney Rank Sum Test. **P ≤ 0.01 (p = 0.002486). Image (h) 
corresponds to a basement membrane surrounding a large cyst (presented in Supplemental Fig. S6e). Note that 
statistical analyses performed without the latter nup133 morphant larva (values indicated by black squares on 
the graph) still revealed a significant difference between the control and the nup133 morphants (p = 0.01855). 
Abbreviations: BS: bowman space; C: capillary lumen; EC: endothelial cells; FP: foot processes. Scale bars 1 µm.
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Several mechanisms could explain the implication of Nup133, and more generally, of Y-complex Nups, in 
glomerular function and thus NS. While it was recently reported that alterations of several Y-Nups including 
NUP133 causes dysregulation of Cdc42 activity in human podocytes, the authors suggested that this was likely 
an indirect effect, possibly linked to altered nucleocytoplasmic transport42. Our immunofluorescence data using 
mAb414 did not reveal any major alteration of overall NPC assembly in nup133 morphants. However, Nup133 
deficiency may alter the nuclear transport of specific molecules, as for instance reported for Nup93 that belongs 
to another structural domain of the NPC14. Indeed, human podocytes and HEK293 cells expressing Nup93 muta-
tions identified in SRNS patients exhibited impaired nuclear import of SMAD4 upon stimulation with bone 
morphogenetic protein 7 (BMP7), a secreted molecule involved in kidney development and response to renal 
injury. This result was consistent with a previous study in which depletion of Drosophila Nup93 led to a defective 
import of the SMAD4 orthologue44. Noteworthy, the latter study also revealed the implication of two Drosophila 
Y-Nups, Nup85/75 and Sec13, but not of Nup133, in this specific import pathway44. While we cannot formally 
exclude Nup133 contribution to the nuclear import of SMAD4 in vertebrates, Nup133 depletion may also affect 
other signaling cascades required for the maintenance of an intact GFB. Indeed, two Y-complex subunits, Nup107 
and Nup37, were reported to be regulators of the ERK and YAP pathways, respectively45,46.
Nup133 knockdown may also alter nuclear mechanotransduction, for instance by interfering with the ‘linker 
of nucleoskeleton and cytoskeleton’ (LINC) complex that establish a stable and cross-linked network between the 
cytoskeleton and the lamina underneath the NE (reviewed in47). Indeed, while Nup133 is required for the proper 
assembly of the NPC basket48, intimate links between the NPC basket, the LINC subunit Sun1 and Lamin-C have 
been reported49,50. As previously discussed16, deregulation of mechanotransduction signaling pathways may in 
turn affect podocytes that are subjected to mechanical stretching caused by capillary pressure. As reported for a 
subset of nucleoporins (reviewed in51), Nup133 may also be involved in gene regulation and thus modulate the 
expression of specific genes required for proper function of the GFB, notably in podocytes.
Finally, one may also keep in mind that several nucleoporins localize at the base of the cilia52,53. In particular, 
another member of the Y-complex, Nup85, was recently reported to be required for proper cilia localization of 
Nup98, a nucleoporin that regulates diffusion of soluble molecules through the ciliary base54. Moreover, muta-
tions affecting the kinetochore protein Cenp-F, an established partner of Nup13355, were identified in patients 
affected by severe ciliopathy and microcephaly56. Because the appearance of kidney cysts in zebrafish can also be 
caused by inactivation of several ciliopathy genes (reviewed in57,58), the observation of a mild Left-Right pattern-
ing defect in nup133 morphants was noteworthy. However, our data revealed that unlike the glomerular cysts 
phenotype, the Left-Right patterning defect is not rescued by the 3xHA-mCherry-Dr nup133 transgene, and is 
therefore not correlated with the glomerular defect observed in these larvae. As previously proposed for other 
mutants37,59,60), the pronephric cyst phenotype observed in the nup133 morphants might thus be primarily caused 
by alterations of the glomerular filtration barrier and the subsequent inability to osmoregulate, rather than the 
indirect consequence of cilia defect. While this non-rescued situs inversus phenotype may reflect an off-target 
effect of the morpholinos (as previously reported in another study)61, we do not formally rule out a possible 
impact of Nup133 depletion on ciliary function. The lack of rescue of the situs inversus by our nup133 construct 
would then reflect an improper expression of the transgene in the Kupffer’s vesicle (the ciliated organ that initiates 
left-right development in the zebrafish embryo)62. Analysis of a potential cell-type-dependent ciliary function of 
Nup133 will deserve a full and independent study.
In conclusion, our study on zebrafish Nup133, together with an increasing number of recent studies correlat-
ing single-gene mutations in Nups with cell type-specific defects, strengthens the emerging concept of specific 
“nucleoporopathies”1, an exciting development in the nuclear pore complex field.
Materials and Methods
Fish maintenance and breeding. Zebrafish (Danio rerio) were kept at 26 °C under a 14-h/10-h light/dark 
cycle and bred as previously described63. Larval stages were raised at 28 °C in E3 embryo medium (5 mM NaCl, 
0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4) containing 0.01% methylene blue. 0.003% PTU (1-phenyl-2-
thiourea; Sigma Aldrich) was added in embryo medium to inhibit melanin synthesis during larval development 
and facilitate fluorescent microscopy. Tg(wt1b:EGFP) line was a kind gift from Dr. Christoph Englert (Leibniz 
Age Research, Jena, Germany). All experiments were performed in accordance with internationally recognized 
and with Swiss legal ethical guidelines for the use of fish in biomedical research and experiments were approved 
by the local authorities (Veterinäramt Zürich Tierhaltungsnummer 150 and TV4206).
Whole-mount in situ hybridization. Sequences were identified and annotated using combined infor-
mation from expressed sequence tags and genome databases (GeneBank, http://www.ncbi.nlm.nih.gov; 
Ensembl, http://www.ensembl.org/index.html). The primers used for probe preparation are listed in supple-
mentary Table S1. nup133, pax2a, wt1a and cdh17 cDNAs were all isolated by RT-PCR from total RNA from 
24–48 hpf embryos and cloned into TOPO pCRII vector (TA Cloning Kit Dual Promoter, Invitrogen) as previ-
ously described64. The resulting plasmids were linearized for SP6 and T7 in vitro transcription and purified with 
phenol-chloroform. Digoxigenin (DIG)-labeled antisense (or sense, as negative control for nup133 expression) 
RNA probes were generated using DIG-RNA-labeling kit (Roche Diagnostic). Zebrafish embryos were fixed in 
4% paraformaldehyde in phosphate-buffered saline (PBS) at 4 °C overnight and whole mount in situ hybridization 
was performed as previously described65. Briefly, on day 1 the larvae were treated with proteinase K and then 
fixed with 4% paraformaldehyde (PFA) before prehybridization at 64 °C. Hybridization of RNA probes was done 
at 64 °C overnight. On day 2, after several stringency washes at 64 °C, probes were blocked in 1 × Roche block-
ing solution in Tris/NaCl/Tween. Anti-DIG AP antibody was applied overnight at 4 °C. On day 3, after several 
washing steps, signal was detected by incubation in staining buffer. Stained embryos were postfixed with PFA 
overnight and imaged in glycerol with an Olympus BX61 light microscope or with a stereomicroscope (Olympus 
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MVX10). Following PFA postfixation, 4 and 5 dpf embryos were cryoprotected in 30% sucrose overnight and 
embedded in tissue freezing medium (Richard-Allan Scientific Neg-50 Frozen Section Medium Thermo Fisher 
Scientific). 14–16 μm transverse sections were cut on a Microm HM 550 cryostat and imaged with a Olympus 
BX61 wide-field microscope (Volketswil, Switzerland). Images were processed and assembled using Adobe 
Photoshop and Adobe Illustrator CS6.
Morpholino and mRNA injections. The nup133 gene was targeted with specific antisense splice-blocking 
Morpholinos (MOs) (GeneTools, Philamath, OR) designed to target the exon-intron boundary of exon 3 (splice 
donor, nup133_E3I3) and the intron-exon boundary of exon 4, respectively (splice acceptor, nup133_I3E4) (MO 
sequences are provided in Supplemental Table S1). The morpholinos were diluted in RNase-free water with 0.1% 
phenol red as an injection tracer and ~1 nl was injected into fertilized embryos at 1–2 cell stage. Uninjected sibling 
embryos and embryos injected with standard control morpholinos were used as controls. Evaluation of morpho-
logical changes was performed at 3 dpf. A range of concentration was first used to determine the optimal MO 
amount required to induce a specific phenotype without inducing toxicity (Supplemental Fig. S3). The two MOs 
were then always injected at 1.75 ng each.
For the rescue experiments, a pBluescript KSM vector containing 3xHA-mCherry-Dr nup133 was used. The 
plasmid was generated using PCR amplification using proofreading DNA polymerases (Phusion HF, NEB) and 
NEBuilder HiFi DNA Assembly Cloning Kits. Briefly, the sequence encoding three copies of the influenza virus 
hemagglutinin (HA) epitope was amplified from pFA6a-3HA-kanMX666, the mCherry was amplified from plasmid 
#193748, full-length zebrafish nup133 was amplified from a Dharmacon cDNA vector (Clone ID: 2600558) and 
the three PCR products were inserted by recombination in a pBluescript KSM vector (Stratagene). PCR-amplified 
fragments and junctions were checked by sequencing. Plasmid map is available upon request. For in vitro mRNA 
production the 3xHA-mCherry-Dr nup133 coding fragment was linearized by digestion with the restriction 
enzyme NotI and purified with phenol-chloroform extraction. Capped and tailed RNA was in vitro transcribed 
using the mMessage mMachine T3 kit (Life Technologies, Zug, Switzerland) according to the manufacturer’s 
instruction. A polyA tail was added with polyA tailing kit (Invitrogen by Thermo Fischer Scientific) followed by 
purification with MEGAclear Transcription Clean-Up Kit (Ambion). The mRNA (300 nM) was injected into the 
embryos at one cell stage before MO injection.
Real-time PCR and real time quantitative PCR. To examine splicing defects caused by nup133_E3I3 
and nup133_I3E4 injection, total RNAs were extracted from 10–40 control or MO-injected embryos at 1 dpf by 
using the ReliaPrep RNA Tissue Miniprep System (Promega), and RNAs were reverse transcribed and amplified 
using SuperScript III First-Strand Synthesis SuperMix with random hexamers (Invitrogen). The resulting cDNAs 
were then characterized by RT-PCR using primers designed from flanking exon-coding sequence (Fig. 2a,b and 
Supplementary Table S1). The RT-PCR products were purified from gel, re-amplified with nested primers and 
altered splicing was confirmed by sequencing.
Real-time quantitative PCR was performed on independent batches of cDNAs from 1, 2 or 5 dpf embryos 
with a LightCycler480 instrument (Roche Life Sciences) by using SYBR Green incorporation (SYBR Green 
PCR-Master Mix; Applied Biosystems) and specific primer pairs (listed in Supplementary Table S1). The relative 
amounts of cDNAs in the samples were quantified according to the manufacturer’s instructions and normalized 
by reference to the actin beta 2 (actb2) cDNAs.
Whole mount live-animal imaging. To evaluate morphological changes, larvae were anesthetized with 
200 mg/ml 3-aminobenzoic acid methyl ester (MESAB, Sigma-Aldrich), mounted in 1.5% low melting temper-
ature agarose in E3 medium and imaged using a stereomicroscope (Olympus MVX10) equipped with a color 
camera (ColorViewIII, Soft imaging System, Olympus).
Western blotting. For western blot analyses, groups of 20–40 embryos at 24 hpf were homogenized by 
sonication in 50–100 µl of Laemmli buffer. The lysates were separated either on 4–20% Mini-Protean® TGX 
Stain-Free™ gel or on NuPAGETM 4–12% Bis-Tris gels, using Tris-Glycine and MOPS as running buffer, respec-
tively, and transferred to nitrocellulose membranes. The resulting blots were stained using Ponceau, saturated 
with TBS, 0.1% Tween, and 5% dried milk and probed overnight at 4 °C with Nup133 antibody (Rabbit mon-
oclonal [EPR10809] to NUP133, ab181355; Abcam, 1:500), rabbit polyclonal anti-ß-Actin (Cell Signaling 
Technology, #4967; 1:1000), or mouse monoclonal antibody HA.11 (clone 16B12; Eurogentec #MMS-101R; 
1:2,000). Incubations of the membrane with primary and HRP-conjugated secondary antibodies (Jackson 
ImmunoResearch Laboratories) were done in TBS buffer (0.1% Tween, 5% dried milk), and signals were detected 
by enhanced chemiluminescence (SuperSignal® West Femto or Pico PLUS; Thermo Scientific).
NPC labeling on cryosections. Because the glomerular phenotype is not fully penetrant (observed, 
depending on the experiment, in 40–90% of the injected embryos, Supplemental Fig. S4), only nup133 MO 
embryos displaying kidney cysts (visualized using the wt1b:GFP transgene) were analyzed. For mAb414 staining, 
3dpf zebrafish larvae were fixed for 30 min in 3% PFA, cryoprotected in 30% sucrose and embedded in tissue 
freezing medium (OCT - Leica 14020108926). Following freezing, 14 μm transverse sections were cut on a Leica 
CM3050S cryostat and placed on SuperFrost Ultra Plus™ adhesion slides (Thermo Scientific). The slides were 
dried for 30 min at 37 °C, washed for 5 min in PBS, saturated for 30 min with PBS containing 0.1% Triton X-100 
and 1% BSA (PBS-T-BSA) and incubated overnight at 4 °C with mAb414 mouse monoclonal antibody (Covance, 
MMS-120P) diluted at 1/5000 in the same buffer. Following rapid washes in PBS-T, slides were then incubated for 
2 hours at room temperature with CY3-conjugated anti-mouse antibody (Jackson ImmuoResearch, # 715-165-
151) diluted 1/500 in PBS-T-BSA containing 0.1 µg/ml DAPI. The slides were then washed in PBS-T and mounted 
in Moviol medium.
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Spinning disk images were acquired on an inverted microscope (DMI8; Leica) with a CSU-W1 spinning disk 
head (Yokogawa) and a sCMOS ORCA-Flash 4 V2+ camera (Hamamatsu) using 100×/1.4 oil objective or a 
20×/0.75 oil objective. Images were acquired without camera binning using MetaMorph (Universal Imaging 
Corp.), processed using ImageJ/Fiji software and assembled using Adobe Photoshop CS. A unique plane is 
presented.
Glomerular filtration assay. Zebrafish larvae at 4 dpf were anesthetized with 200 mg/ml 3-aminobenzoic 
acid methyl ester (MESAB, Sigma-Aldrich). 1 nl of Albumin from bovine serum (BSA), Alexa Fluor 647 con-
jugate (Thermo Fischer scientific) was injected into the common cardinal vein according to38. The larvae were 
transferred to E3 medium for recovery. 20 mins after injections, the larvae were fixed in 4% PFA overnight and 
processed for cryosections and imaging.
Transmission electron microscopy and histology. Zebrafish larvae at 5 dpf were fixed overnight in 
2.5% glutaraldehyde (along with 3% EM grade PFA for the larvae shown in Fig. 7h and in Supplementary Figs. S6, 
panels b, d and e, and S7, panel f) in 0.1 M cacodylate buffer, pH 7.2. As indicated above for the IF studies, nup133 
MO embryos displaying kidney cysts were selected prior to EM studies. To achieve a better penetration of the 
fixative, the tail of each larva was cut off with a scalpel prior to fixation. The larvae were rinsed in 0.1 M cacodylate 
buffer before postfixation in 1% osmium tetroxide in cacodylate buffer for 1 hour at room temperature. The sam-
ples were rinsed in distilled water before en block staining in 1% aqueous uranyl acetate for 1 hour at room tem-
perature. Following dehydration through a graded series of ethanol ranging from 50% to 100%, the larvae were 
infiltrated overnight in 66% Epon/Araldite in propylene oxide. Finally, the specimens were embedded in 100% 
Epon/Araldite and placed in a polymerizing oven at 60 °C for 26 h. Semi thin section (2 µm) were stained with 
toluidine blue and used for histological studies. Ultrathin sections (65 nm) of the glomerulus and the proximal 
tubules, obtained using a Leica EM FCS ultramicrotome were collected on formvar coated copper grids, stained 
in lead for 5 minutes to increase the contrast, and examined with a Philips CM-100 scope at 80 kV. Images were 
acquired using the Gatan Microscopy Software.
For quantification of FP density, images acquired from 3 control and 3 nup133-MO treated embryos were 
analyzed. For each embryo, the number of foot processes and the length of the basement membrane were meas-
ured from 3–5 distinct fields each. Images used for quantification, the selected ROI, and original Excel file used to 
generate the graph are available at Mendeley under https://doi.org/10.17632/j78ddshctz.1.
Statistical analyses were performed using Wilcoxon-Mann-Whitney Rank Sum Test provided by the 
KaleidaGraph software.
Data Availability
pBluescript KSM vector containing 3xHA-mCherry-Dr nup133 and its sequences are available upon request. Im-
ages used for EM quantification (Fig. 7g) and for the quantifications of kidney cysts appearance, LR asymmetry 
(based on pancreas positioning) and head sizes (Supplemental Fig. S5) are available at Mendeley under https://
doi.org/10.17632/j78ddshctz.1.
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